Danya Institute Inc.

Overdose

More than 321,000 U.S. children lost a parent to drug overdose from 2011 to 2021

Earlier this month, SAMHSA released a press announcement revealing that based on a study published by JAMA Psychiatry, from 2011 to 2021, an estimated 321,566 children in the United States lost a parent to drug overdose, with rates more than doubling during this period. The study, led by researchers at NIH, SAMHSA, and CDC, highlights the disproportionate impact […]


NSDUH 2022 Data Available

SAMHSA has just released the 2022 National Survey on Drug Use and Health results, accompanied by a newly offered companion infographic. The 2022 sample size was 71,369 and used multi-mode collection methods in gathering the self-reported data from respondents. Some findings include the following results: Among the 137.4 million (or 48.7%) current alcohol users aged 12 or […]


National Recovery Month

National Recovery Month 2023 National Recovery Month 2022 National Recovery Month 2021 National Recovery Month 2020 National Recovery Month 2019 National Recovery Month 2018


ORN Regional Summit

Submit a request for similar summits, speakers, technical assistance, or trainings!!!    


Fentanyl Bill Passes House

From MedPage House Passes Bill to Address Fentanyl Overdoses — But critics say the HALT Fentanyl Act is the wrong way to approach the problem by Joyce Frieden The House passed a bill Thursday that proponents say is designed to reduce the number of people who become addicted to fentanyl, but opponents say it won’t […]


Tranq in Philly’s fentanyl supply

From CNN. Tranq has become a bigger part of Philly’s street fentanyl supply. The wounds left behind are killing people by Elle Reeve, Samantha Guff, and Deborah Brunswick Philadelphia (CNN) — What drug users and people who work with them in Philadelphia talk about is the smell. The smell of rotting flesh from open infected wounds. Some […]


FDA to Restrict Xylazine

From the FDA February 28, 2023 FDA Takes Action to Restrict Unlawful Import of Xylazine Agency Aims to Maintain Availability for Legitimate Use in Animals while Preventing Importation for Illicit Purposes Today, the U.S. Food and Drug Administration announced that it has taken action to restrict the unlawful entry of xylazine active pharmaceutical ingredients and finished dosage […]


FDA panel to review OTC Narcan

From Reuters U.S. FDA panel to review Emergent’s OTC opioid overdose drug Jan 10 (Reuters) – The U.S. health regulator said on Tuesday its advisory panel will meet on Feb. 15 to review Emergent Biosolutions Inc’s (EBS.N) over-the-counter (OTC) nasal spray to treat suspected opioid overdoses. Emergent is seeking the Food and Drug Administration’s (FDA)approval for the […]


MOUD Expansion

SAMHSA Applauds Expansion of Access to Medication for Opioid Use Disorder (MOUD) January 18, 2023